Hospital Acquired Infection Control Market Report: By Product Type (Consumables, Instruments), Procedure Type (Disinfection, Sterilization), End User (Hospitals & Clinics, Infection Control Service Providers, Ambulatory Surgical Care Centers) – Global Industry Size and Share Forecast to 2030

Market Overview

The global hospital-acquired infection control market was valued at $30,224.7 million revenue in 2021. The market size is predicted to reach $34,909.7 million by 2030, advancing at a CAGR of 1.6% during 2021–2030. The market will be driven by the increasing number of surgical procedures, growing awareness of environmental & personal hygiene, and subsequent growth in the prevalence of chronic diseases.

All hospitalized patients are susceptible to contracting a nosocomial infection. Young children, the elderly, and people with weakened immune systems are all more susceptible to hospital infections than others. The major risk factors for the infections include long hospital stays, use of indwelling catheters, failure of healthcare staff to wash their hands, and overuse of antibiotics. Also, HAIs kill more people each year globally than car accidents, breast cancer, or AIDS. Thus, there is an utmost necessity to control HAIs.

Moreover, due to the rising awareness among customers in the midst of the COVID-19, the demand for personal hygiene and environmental awareness is projected to surge even more in the upcoming period. The pandemic has made consumers more aware of the need to maintain hygiene, at a personal level as well as in public places, to reduce the chances of infection and this is expected to become a trend in the long run.

The rate of HAIs significantly increased during the pandemic, with the rise in nursing hours. During the period, the medical device-related infections, catheter-associated urinary tract infections (CAUTIs), and central line-associated bloodstream infections (CLABSIs) were also increased, due to the change in the complexity of hospitalized patients and safety practices that were implemented to decrease virus transmission risk to healthcare providers. Thus, the control measures were taken at a very higher pace, which impacted the hospital-acquired infection control market positively during the pandemic time.

Increasing Number of Surgical Procedures

In recent years, a drastic increase in incidences of neurological disorders, traumatic injuries, and cardiovascular diseases, and the introduction of advanced surgical technologies have been witnessed. Due to these repeated events, the market for HAI control products is increasing. For instance, every year, the number of people suffering from neurological illnesses or accidents is about 20 million and around 14 million of them require surgery.

Also, technologies have become an integral part of patient care. The introduction of new surgical technologies in operating rooms has helped avoid the consequences of human error. For this, also many new procedures, from invasive to less invasive and even non-invasive surgical procedures, are introduced at a higher pace. However, after the deployment of the advanced equipment and technologies, they require maintenance and prevention from infections, which may occur. Thus, sterilization, disinfection, and other controlled procedures are highly required in healthcare facilities.

Therefore, the rising number of surgical procedures performed has resulted in the increasing need for different surgical equipment and medical devices. This drives the demand for HAI control solutions, due to demonstrated benefits of sterilized items and increased awareness of their effectiveness in healthcare settings.

Furthermore, there are many awareness programs introduced by various governmental and nonprofit organizations to reduce the loss of lives globally, which is expected to provide ample opportunities for the market. For instance, according to CDC, about 6–7% of the population lose their lives due to HAIs in developed countries, whereas in developing countries about 10–12% population are affected by these infections. The WHO had introduced an awareness program known as Patient Safety Solutions, in which the organization promoted hand hygiene adherence as a health care facility on priority to reduce the burden of infectious diseases.

Explore more about this report - Request free sample pages

Demand for HAI Control in Ambulatory Surgical Care Centers Is Increasing

The demand for HAI control products in ambulatory surgical care centers is expected to grow at the highest CAGR, of 2%, during 2021–2030, in the market. This can be ascribed to the increasing footfall of patients in ambulatory surgical care centers, as many people are unable to afford the cost of treatment, especially for surgical operations, in hospitals. This has led to the introduction of an economical system without disrupting the quality. Thus, ambulatory surgical centers are becoming the solution to these problems.

Disinfection Type of Procedure Is Increasingly Adopted

Disinfection is a widely used procedure in the market, holding a revenue share of more than 68% in 2021. Hospitals are attempting to lower the rates of HAIs. These infections can appear 48–72 hours after a patient's admission and persist for up to 10 days after discharge. To prevent these infections, the adoption of disinfection is increasing. Some immediately used disinfectants to avoid such issues are formaldehyde, glutaraldehyde, and hydrogen peroxide.

North America Held the Largest Market Share

North America accounted for the largest share, of 35%, in the hospital-acquired infection control market. This is attributed to the surge in the geriatric population, the increase in the prevalence of chronic diseases and HAIs, and the presence of prominent market players in the region. For instance, in the U.S., the number of populations aged above 65 years is around 45 million and it is expected to reach above 80 million by 2050. Moreover, the prevalence of HAIs in North America is very prominent. For example, in American hospitals, the prevalence of HAIs is above 1.5 million, and every year, 0.1 million death occurs due to this.

Whereas, the APAC market is expected to grow at the highest CAGR in the forecast period. In developing and underdeveloped countries of the region, the demand for HAI control solutions is increasing, owing to the surging number of patients and economic expansion in these areas. Moreover, the adoption rate of advanced medical equipment is increasing, as governments offer several supports to stimulate the improvement in medical expenditure and infrastructure. As a result, the demand for HAI control measures is projected to rise in APAC.

Market Players Are Involving in Acquisitions and Partnerships to Gain Competitive Edge

The hospital-acquired infection control market is fragmented in nature, with the presence of several major players. In recent years, they have pursued acquisitions and partnerships, in order to stay ahead of their competitors. For instance:

• In November 2021, Sotera Health Company acquired Wisconsin-based Regulatory Compliance Associates (RCA). With this acquisition, the company has planned to expand quality, regulatory, and technical consulting capabilities in the U.S.
• In September 2021, Ecolab Inc. partnered with Sodexo for the prevention of HAIs. This partnership is to deliver a new infection prevention offering for hospitals and healthcare facilities across the U.S. by a unique program known as Protecta Plus. This provides an additional solution to help reduce the risk of infection with Ecolab’s Bioquell hydrogen peroxide vapor technology.

Key Players of the Market Are:

• STERIS plc
• Sotera Health Company
• Getinge AB
• Advanced Sterilization Products (ASP)
• Ecolab Inc.
• 3M Company
• MATACHANA GROUP
• Belimed AG
• Reckitt Benckiser
• Contec Inc.

Market Size Breakdown by Segment

The report offers comprehensive market segmentation analysis along with market estimation for the period 2017–2030.

Based on Product Type

• Consumables
• Instruments

Based on Procedure Type

• Disinfection
• Sterilization
  • Steam sterilizers
  • Low temperature sterilizers
  • Heat sterilizers
  • Radiation sterilizers
  • Filtration sterilizers
  • Liquid sterilizers
  • Ultrasonic sterilizers 

Based on End User

• Hospitals & Clinics
• Infection Control Service Providers
• Ambulatory Surgical Care Centers

Geographical Analysis

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • France
  • U.K.
  • Italy
  • Spain
• Asia-Pacific (APAC)
  • China
  • India
  • Japan
  • Australia
  • South Korea
• Latin America (LATAM)
  • Brazil
  • Mexico
• Middle East and Africa (MEA)
  • Saudi Arabia
  • South Africa